目的：建立盐酸氨溴索的HPLC含量测定方法。
Objective: To develop an HPLC method for assay of ambroxol hydrochloride.
目的：研究盐酸氨溴索对喘息小儿肺功能的影响。
Objective: to study the effect of ambroxol as a bronchodilator on infants with wheezing disease.
结论盐酸氨溴索分散片在水中能迅速崩解并均匀分散。
Conclusion the ambroxol hydrochloride dispersible tablets can disintegrate quickly in the water and disperse homogeneously.
结果：制得的盐酸氨溴索渗透泵控释片释放度符合要求。
Results: The release rate of ambroxol hydrochloride osmotic pump controlled release tablets prepared was conformed to requirement.
前言：目的：研究盐酸氨溴索渗透泵控释片的体外释放度。
Objective: To study the in vitro release rate of ambroxol HCl osmotic pump controlled release tablets.
目的：确立盐酸氨溴索氯化钠注射液细菌内毒素检查方法。
Objective: to establish a method of test for bacteria endotoxin of ambroxol hydrochloride and sodium chloride injection.
结果表明，所建模型可用于盐酸氨溴索片的快速识别分析。
The developed identification system was successfully used to identify ambroxol hydrochloride tablets from different manufacturers.
方法18只豚鼠随机分为正常对照组、哮喘模型组、氨溴索组。
Methods: 18 guinea-pigs were randomized into normal control group, bronchial asthma group and ambroxol group.
目的探讨盐酸氨溴索对控制重型颅脑损伤患者肺部感染的作用。
Objective To study the effect of Mucosolvan on management of lung infection in the patients after severe brain injury.
目的观察盐酸氨溴索联合654-2佐治毛细气管炎的临床疗效。
OBJECTIVE To observe the clinical effects of ambroxol hydrochloride combined with 654-2 in treatment with capillary tracheitis.
目的：探讨氨溴索对低氧性肺动脉高压大鼠慢性肺损伤的对抗作用。
AIM: To investigate the effect of ambroxol on pulmonary and vascular injury in chronically hypoxic rats.
采用近红外光谱定性分析法对不同厂家的盐酸氨溴索片进行快速识别。
A rapid identification system for ambroxol tablets from different manufacturers using NIR was developed.
目的制备盐酸氨溴索药物树脂复合物并对其体外释药动力学进行考察。
The drug release kinetics were also investigated in different releasing mediums(deionic water, 0.
目的：对国产盐酸氨溴索口腔崩解片和进口普通片进行生物等效性研究。
OBJECTIVE To study the bioequivalence of ambroxol hydrochloride orally disintegrating tablets in Chinese healthy volunteers.
目的考察注射用硫酸头孢噻利与盐酸氨溴索氯化钠注射液配伍的稳定性。
Objective To study the compatible stability of cefoselis sulfate injection and ambroxol hydrochloride injection.
结果盐酸氨溴索葡萄糖注射液用鲎试剂检测细菌内毒素无干扰因素的影响。
Results Endotoxin added to Ambroxol Hydrochloride Glucose Injection was recovered in a quantitative manner showing neither inhibition nor enhancement.
目的：探讨氨溴索对早产儿呼吸窘迫综合征(NRDS)的预防和治疗作用。
Objective: to evaluate the effect of ambroxol in preventing and treating neonatal respiratory distress syndrome (NRDS).
结论盐酸氨溴索、布地奈德混悬液氧气驱动雾化吸入防治NRDS有较好疗效。
Conclusion Inhaled ambroxol hydrochloride and budesonide suspension treatment has be well effect in NRDS.
综述了氨溴索的药理作用(具有促胎肺成熟、粘痰溶解、抗炎症和抗氧化等作用)。
The pharmacological effects of ambroxol including mucolytic role, fetal lung maturating, anti inflammation, antioxidation are reviewed.
结论：盐酸氨溴索渗透泵控释片释药稳定，零级释药明显，具备优良控释制剂的特征。
Conclusions: The ambroxol HCl osmotic pump controlled release tablets have a stable release curve and conform to zero release order.
前言： 目的：观察盐酸氨溴索（沭舒坦）对慢性支气管炎（慢支）患者术后的疗效。
Objectives: To observe the effect of ambroxol hydrochloride on chronic bronchitis after surgery.
结论：盐酸氨溴索可抑制哮喘大鼠气道gch，改善哮喘气道炎症，对哮喘的防治有一定作用。
CONCLUSION: Ambroxol can alleviate the airway inflammation and suppress GCH in chronic asthmatic rats. Ambroxol is valuable in the prophylaxis and treatment of asthma.
方法盐酸氨溴索咀嚼片的溶出度测定采用紫外分光光度法，其含量测定则采用高效液相色谱法。
Methods UV spectrophotography was used to determine the dissolution of ambroxol hydroehloride chewing tablets, and HPLC was used to determine content of ambroxol hydroehloride.
结论AECOPD患者应用氨溴索联合布地奈德雾化吸入治疗，可明显提高疗效，值得临床推广。
Conclusions AECOPD patients application ammonia bromine joint budesonide atomization inhalation treatment can evidently improve curative effect, worth clinical promotion.
目的：观察雾化吸入盐酸氨溴索对慢性阻塞性肺病（COPD）急性发作期患者痰液理化性质的影响。
Objective: To investigate the influence of ambroxol hydrochloride for atomizing inhalation on the phlegm liquid and to explore a new way to treat chronic obstructive pulmonary disease (COPD).
结论：采用盐酸氨溴索和多巴胺、酚妥拉明联合CPAP治疗轻、中度新生儿呼吸窘迫综合征效果较好。
Conclusion: The combined use of CPAP and ambroxol, dopamine and phentolamine has good effects on slight and mild neonatal respiratory distress syndrome.
对20种制剂用建立的分析技术进行了检测，经与相应的标准物质比较，得到20种样品均未含氨溴索。
The 20 kinds of preparations were detected by established analysis technology, and compared with the corresponding standard substances ambroxol was not obtained with the 20 kinds of samples.
本发明的含氨溴索与福莫特罗活性成分的药物制剂具有性质稳定，使用方便，适用于大生产化的特点。
The drug preparation containing the active ingredients of the ambroxol and the formoterol is characterized by stable property, convenient use, and being applicable for large-scale production.
结论布地奈德联合氨溴索雾化吸入治疗COPD急性加重期疗效好，无明显不良反应，值得临床推广使用。
Conclusion Aerosol inhalation of budesonide combined with ambroxol in treatment of acute exacerbation of COPD has good efficacy, no adverse reactions, is worthy of clinical use.
结论布地奈德联合氨溴索雾化吸入治疗COPD急性加重期疗效好，无明显不良反应，值得临床推广使用。
Conclusion Aerosol inhalation of budesonide combined with ambroxol in treatment of acute exacerbation of COPD has good efficacy, no adverse reactions, is worthy of clinical use.
应用推荐